Amgen Patent Suit Targets Coherus' Neulasta Biosimilar
Amgen Inc. on Wednesday sued biosimilar maker Coherus Biosciences Inc. in Delaware federal court for allegedly infringing a patent covering anti-infection medicine Neulasta, marking its latest court fight to protect the...To view the full article, register now.
Already a subscriber? Click here to view full article